These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9298835)

  • 21. CD4-T cell enumeration in human immunodeficiency virus (HIV)-infected patients: A laboratory performance evaluation of Muse Auto CD4/CD4% system by World Health Organization prequalification of in vitro diagnostics.
    Ceulemans A; Bouzahzah C; Prat I; Urassa W; Kestens L
    PLoS One; 2019; 14(1):e0209677. PubMed ID: 30673713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of CD4 cell count by a simple enzyme-linked immunosorbent assay using the TRAx CD4 test kit and by flow cytometry and hematology.
    Paxton H; Pins M; Denton G; McGonigle AD; Meisner PS; Phair JP
    Clin Diagn Lab Immunol; 1995 Jan; 2(1):104-14. PubMed ID: 7719901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.
    Evans TG; Bonnez W; Soucier HR; Fitzgerald T; Gibbons DC; Reichman RC
    Antiviral Res; 1998 Oct; 39(3):163-73. PubMed ID: 9833957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.
    Price DA; Scullard G; Oxenius A; Braganza R; Beddows SA; Kazmi S; Clarke JR; Johnson GE; Weber JN; Phillips RE
    J Virol; 2003 May; 77(10):6041-9. PubMed ID: 12719595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+ T-lymphocyte count/CD8+ T-lymphocyte count ratio: surrogate for HIV infection in infants?
    Navaneethapandian PG; Karunaianantham R; Subramanyan S; Chinnayan P; Chandrasekaran P; Swaminathan S
    J Trop Pediatr; 2012 Oct; 58(5):394-7. PubMed ID: 22228820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External quality assessment program on CD4+ T-lymphocyte counts for persons with HIV/AIDS in Thailand: history and accomplishments.
    Pobkeeree V; Lerdwana S; Siangphoe U; Noulsri E; Polsrila K; Nookhai S; Pattanapanyasat K
    Asian Pac J Allergy Immunol; 2009 Dec; 27(4):225-32. PubMed ID: 20232577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between T-subsets and clinical aspects of HIV-associated diseases].
    Fuchs M; Stadler BM; Malinverni R; de Weck AL; Pichler WJ
    Schweiz Med Wochenschr; 1991 Jan; 121(3):57-66. PubMed ID: 1671535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
    Hulgan T; Raffanti S; Kheshti A; Blackwell RB; Rebeiro PF; Barkanic G; Ritz B; Sterling TR
    J Infect Dis; 2005 Sep; 192(6):950-7. PubMed ID: 16107946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy.
    Staszewski S; Miller V; Sabin C; Schlecht C; Gute P; Stamm S; Leder T; Berger A; Weidemann E; Hill A; Phillips A
    AIDS; 1999 May; 13(8):951-6. PubMed ID: 10371176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
    Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standardization of absolute CD4+ lymphocyte counts across laboratories: an evaluation of the Ortho CytoronAbsolute flow cytometry system on normal donors.
    Connelly MC; Knight M; Giorgi JV; Kagan J; Landay AL; Parker JW; Page E; Spino C; Wilkening C; Mercolino TJ
    Cytometry; 1995 Sep; 22(3):200-10. PubMed ID: 8556951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune restoration by combination of a cytostatic drug (hydroxyurea) and anti-HIV drugs (didanosine and indinavir).
    Lori F; Jessen H; Lieberman J; Clerici M; Tinelli C; Lisziewicz J
    AIDS Res Hum Retroviruses; 1999 May; 15(7):619-24. PubMed ID: 10331440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression.
    Schechter M; Harrison LH; Halsey NA; Trade G; Santino M; Moulton LH; Quinn TC
    JAMA; 1994 Feb; 271(5):353-7. PubMed ID: 7904317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+ T cell enumeration in HIV infection with limited resources.
    Sherman GG; Galpin JS; Patel JM; Mendelow BV; Glencross DK
    J Immunol Methods; 1999 Jan; 222(1-2):209-17. PubMed ID: 10022387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment initiation with zidovudine-containing potent antiretroviral therapy impairs CD4 cell count recovery but not clinical efficacy.
    Huttner AC; Kaufmann GR; Battegay M; Weber R; Opravil M
    AIDS; 2007 May; 21(8):939-46. PubMed ID: 17457087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD4/CD8 lymphocyte counts in healthy, HIV-positive individuals & AIDS patients.
    Ray K; Gupta SM; Bala M; Muralidhar S; Kumar J
    Indian J Med Res; 2006 Sep; 124(3):319-30. PubMed ID: 17085836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rate of decline of absolute number and percentage of CD4 T lymphocytes among HIV-1-infected adults in Dar es Salaam, Tanzania.
    Urassa W; Bakari M; Sandström E; Swai A; Pallangyo K; Mbena E; Mhalu F; Biberfeld G
    AIDS; 2004 Feb; 18(3):433-8. PubMed ID: 15090795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
    Jankelevich S; Mueller BU; Mackall CL; Smith S; Zwerski S; Wood LV; Zeichner SL; Serchuck L; Steinberg SM; Nelson RP; Sleasman JW; Nguyen BY; Pizzo PA; Yarchoan R
    J Infect Dis; 2001 Apr; 183(7):1116-20. PubMed ID: 11237839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.